Answers are grounded in this paper and cite their sources.
Gender differences in the access to advanced therapies for Parkinson's disease (PD) are poorly investigated.
No takes yet. Share an insight, caveat, or question.
Maccarrone et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: